Abstract
Background: Low-dose radiotherapy (LD-RT) has produced anti-inflammatory effects in both animal models and early human trials of COVID-19-related pneumonia. The role of whole-lung LD-RT within existing treatment paradigms merits further study.
Methods: A phase II prospective trial studied the addition of LD-RT to standard drug treatments. Hospitalized and oxygen-dependent patients receiving dexamethasone and/or remdesevir were treated with 1.5 Gy whole-lung LD-RT and compared to a blindly-matched contemporaneous control cohort.
Results: Of 40 patients evaluated, 20 received drug therapy combined with whole-lung LD-RT and 20 without LD-RT. Intubation rates were 14% with LD-RT compared to 32% without (p = 0.09). Intubation-free survival was 77% vs. 68% (p = 0.17). Biomarkers of inflammation (C-reactive protein, p = 0.02) and cardiac injury (creatine kinase, p < 0.01) declined following LD-RT compared to controls. Mean time febrile was 1.4 vs 3.3 days, respectively (p = 0.14). Significant differences in clinical recovery (7.5 vs. 7 days, p = 0.37) and radiographic improvement (p = 0.72) were not detected. On subset analysis, CRP decline following LD-RT was predictive of recovery without intubation compared to controls (0% vs. 31%, p = 0.04), freedom from prolonged hospitalizations (21+ days) (0% vs. 31%, p = 0.04), and decline in oxygenation burden (56% reduction, p = 0.06). CRP decline following 1st drug therapy was not similarly predictive of outcome in controls (p = 0.36).
Conclusions: Adding LD-RT to standard drug treatments reduced biomarkers of inflammation and cardiac injury in COVID-19 patients and may have reduced intubation. Durable CRP decline following LD-RT predicted especially favorable recovery, freedom from intubation, reduction in prolonged hospitalization, and reduced oxygenation burden. A confirmatory randomized trial is now ongoing.
Clinical trial registration: NCT04366791 .
Keywords: COVID-19; Low-dose radiation; Pneumonia.
【저자키워드】 COVID-19, Pneumonia, breath, Low-dose radiation, 【초록키워드】 Dexamethasone, Treatment, Inflammation, Anti-inflammatory effects, therapy, Biomarkers, Trial, Hospitalization, Pneumonia, creatine, randomized trial, Intubation rates, intubation, C-reactive protein, CRP, oxygen, animal model, outcome, drug therapy, clinical recovery, cardiac injury, Cohort, survival, Radiotherapy, clinical, low-dose, Patient, Control, drug treatment, creatine kinase, Analysis, Injury, COVID-19 patient, Oxygenation, drug treatments, Predictive, reduction, Prospective trial, significant differences, Radiographic, anti-inflammatory effect, febrile, controls, produced, predicted, addition, receiving, reduced, treated, reduction in, subset, Significant, Adding, declined, biomarkers of inflammation, patients evaluated, 【제목키워드】 Pneumonia, Non-intubated, Patient, radiation therapy, receiving,